Google parent company Alphabet Inc. has launched a new company in London called Isomorphic Labs. The company aims to use AI (artificial intelligence) for drug discovery and medicine to find cures for some of humanity’s most devastating diseases. Demis Hassabis will be the CEO of Isomorphic Labs. Hassabis is the CEO and co-founder of DeepMind, another Alphabet subsidiary that used AI to predict the 3D structure of a protein directly from its amino acid sequence.
The London-based Isomorphic Labs will work on the most important applications of AI — in the field of biological and medical research. The company aims to use AI to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases. The new venture also plans to partner with biomedical and pharmaceutical companies, using artificial intelligence to discover new medicinal advancements.
Important takeaways for all competitive exams
Super Typhoon Man-yi, locally known as Pepito, has made a second landfall on the Philippines'…
In a significant move to expand its global presence, Australia’s University of Wollongong (UOW) has…
In a major development, the United States has returned over 1,400 looted artifacts worth $10…
Karnataka Bank Ltd. has introduced two student-focused financial products, ‘KBL Peak’ and ‘KBL Genius’, aiming…
Many countries have special nicknames that reflect their unique features, history, or natural beauty. These…
Moody’s Ratings has projected steady growth for India, maintaining its forecast of 7.2% GDP growth…